Overview

Cellanome offers an automated platform that allows researchers to study individual cell behaviors and interactions under various conditions. The platform enables live cell phenotypic and functional assays, providing detailed insights into how cells respond to different stimuli over time. Unlike traditional methods that focus on bulk responses, Cellanome highlights the unique reactions of individual cells, making it a valuable tool in life sciences and medical research. The company's goal is to enhance research in cell biology by providing a scalable and precise tool for understanding cellular behaviors.

Simplify's Take

What believers are saying

• Rising demand for personalized medicine aligns with Cellanome's focus on individual cell behaviors.
• Growing trend in microfluidics enhances Cellanome's scalable solutions for cell biology research.
• Collaborations with pharmaceutical companies offer opportunities for joint ventures and technology sharing.

What critics are saying

• Increased competition in single-cell analysis could impact Cellanome's market share.
• Ethical concerns about cellular manipulation may lead to regulatory challenges.
• Economic downturns could reduce demand for Cellanome's platform from research institutions.

What makes Cellanome unique

• Cellanome's platform offers unprecedented detail in individual cell behavior analysis.
• The company integrates seamlessly into existing workflows, enhancing research without major disruptions.
• Cellanome's focus on live cell assays provides a more granular analysis than traditional methods.

Help us improve and share your feedback! Did you find this helpful?

YesNo

Funding

Total Funding

$195.5M

Above

Industry Average

Funded Over

2 Rounds

$150,000,000

Series B

Jan 2024

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.

Series B Funding Comparison

Above Average

Industry standards

Ind Avg. $35M

$4M

$30M

$45M

$65M

$100M

$150M

View all funding stages